Finance

Lists
Why is MRVL down 5.00%?
Dive Deeper
MRVL:CVE
Marvel Biosciences Corp
CA$0.095
-5.00%
(-0.0050) 1D
Oct 19, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVL...
Open
CA$0.10
High
CA$0.10
Low
CA$0.10
Mkt. cap
6.00M
Avg. vol.
118.54K
Volume
27.52K
52-wk high
CA$0.25
52-wk low
CA$0.10
EPS
-CA$0.03
Beta
0.22
Shares outstanding
63.03M
Open
CA$0.10
High
CA$0.10
Low
CA$0.10
Mkt. cap
6.00M
Avg. vol.
118.54K
Volume
27.52K
52-wk high
CA$0.25
52-wk low
CA$0.10
EPS
-CA$0.03
Beta
0.22
Shares outstanding
63.03M
News stories
From web sources and news partners
About Marvel Biosciences Corp
CEO-
Employees-
Founded2021
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websitemarvelbiotechnology.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
250.56K
57.46K
5.26K
72.14K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
220.93K
189.29K
245.38K
262.03K
Operating expense
488.69K
252.83K
256.72K
340.06K
Total operating expenses
488.69K
252.83K
256.72K
340.06K
Operating income
-488.69K
-252.83K
-256.72K
-340.06K
Other non operating income
-531.64K
-10.52K
-14.17K
458.25K
EBT including unusual items
-1.19M
-342.26K
-295.58K
436.71K
EBT excluding unusual items
-1.19M
-342.26K
-295.58K
80.92K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.19M
-342.26K
-295.58K
436.71K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
72.00
-
-
-
Interest expense
-161.77K
-56.40K
-56.35K
-40.27K
Net interest expenses
-161.70K
-56.40K
-56.35K
-40.27K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps